PAVM – pavmed inc. (US:NASDAQ)

News

PAVmed (PAVM) had its price target lowered by Ascendiant Capital Markets from $510.00 to $65.00. They now have a "buy" rating on the stock.
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment [Yahoo! Finance]
PAVmed (PAVM) was upgraded by Wall Street Zen from "sell" to "hold".
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com